Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.
about
Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis.Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine-associated erythema nodosum.Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
P2860
Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@en
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@nl
type
label
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@en
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@nl
prefLabel
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@en
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@nl
P2860
P1433
P1476
Combined, reduced-antigen cont ...... ls aged 10-64 years in the US.
@en
P2860
P304
P356
10.2165/11202770-000000000-00000
P577
2009-01-01T00:00:00Z
P6179
1011577430